Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 41

Sort by

Sort Order Select

Journal Articles

Diagnostic Potential of Five Different Biomechanical Parameters to Detect Sclerotic Cutaneous Graft-Versus-Host Disease

Fuyao Chen, BS, Laura Wang, BS, Yvette Ssempijja, BS, Arved Vain, PhD, Madan Jagasia, MBBS, MS, MMHC, Eric R. Tkaczyk, MD PhD

Blood (2019) 134 (Supplement_1): 2002.

https://doi.org/10.1182/blood-2019-129381

Published: 2019

Journal Articles

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Guldane Cengiz Seval, Atilla Uslu, MD, Ekin Kircali, Sinem Civriz Bozdag, MD, Klara Dalva, MD, Selami Kocak Toprak, MD, Meltem Kurt Yuksel, MD, Pervin Topcuoglu, MD, Isinsu Kuzu, Onder Arslan, Muhit Özcan, Taner Demirer, MD, Osman Ilhan, MD, Hamdi Akan, MD, Meral Beksac, MD, Gunhan Gurman, MD

Blood (2019) 134 (Supplement_1): 2019.

https://doi.org/10.1182/blood-2019-128750

Published: 2019

Journal Articles

Interobserver Reproducibility of the Myoton and Durometer Devices to Measure Skin Stiffness and Hardness in Chronic Cutaneous Graft-Versus-Host Disease Patients

Fuyao Chen, BS, Laura Wang, BS, Arved Vain, PhD, Yvette Ssempijja, BS, Laura Dellalana, BS, Kathy Zhang, Alexis Hood, BS, Heidi Chen, PhD, Madan Jagasia, MBBS, MS, MMHC, Eric R. Tkaczyk, MD PhD

Blood (2019) 134 (Supplement_1): 4515.

https://doi.org/10.1182/blood-2019-129125

Published: 2019

Journal Articles

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Tsiporah B. Shore, MD, Jessy B. Ryan, ANP, Michael B. Samuel, MD

Blood (2019) 134 (Supplement_1): 5687.

https://doi.org/10.1182/blood-2019-122715

Published: 2019

Journal Articles

Outcomes after Third Party, Viral-Specific, Cytotoxic Lymphocytes for Immunosuppression- and Epstein-Barr Virus-Associated Lymphoproliferative Disease

Sajida Kazi, MRCP, FRCPATH, Abhinav Mathur, MBChB, Gwen M. Wilkie, BSc, MSc, Kirsty Cheal, BSc, MSc, Richard Battle, BSc, PhD, Neil McGowan, BSc, Emily Jane Hargreaves, BSc, David Turner, BSc, PhD, John D.M. Campbell, BSc, PhD, Marc Turner, BM, BCh, PhD FRCP, Mark A Vickers, MB ChB, DM, FRCPath

Blood (2018) 132 (Supplement 1): 3329.

https://doi.org/10.1182/blood-2018-99-114477

Published: 2018

Journal Articles

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)

Ridhi Gupta, MD, Abdulwahab Albabtain, MD, Sally Arai, MD, Bernice Kwong, MD, Wen-Kai Weng, MD PhD

Blood (2018) 132 (Supplement 1): 3409.

https://doi.org/10.1182/blood-2018-99-113915

Published: 2018

Journal Articles

Stem Cell Transplantation in Advanced Stage Sickle Cell Disease with Haploidentical T-Cell Depleted PBSC Yields Comparable Outcomes to Matched Sibling Donor Bone Marrow: Results of a Pilot Study

Juergen Foell, MD, Johannes Schulte, Anja Troeger, MD, Beatrix Pfirstinger, MD, Daniel Wolff, MD, Matthias Edinger, MD PhD, Ernst Holler, MD, Petra Hoffmann, PhD, Charalampos Aslanidis, PhD, Wolfgang Herr, MD, Angelika Eggert, MD PhD, Selim Corbacioglu, MD

Blood (2018) 132 (Supplement 1): 3455.

https://doi.org/10.1182/blood-2018-99-114695

Published: 2018

Journal Articles

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

Lihua Budde, MD PhD, Joo Y Song, MD, Young Kim, MD, Suzette Blanchard, PhD, Jamie Wagner, BS, Anthony S. Stein, MD, Lihong Weng, MD, Marissa Del Real, PhD, Rochelle Hernandez, Emanuela Marcucci, Jennifer K Shepphird, PhD, Xiuli Wang, PhD, Brent Wood, MDPhD, Guido Marcucci, MD, Christine E Brown, PhD, Stephen J. Forman, MD FACP

Blood (2017) 130 (Supplement 1): 811.

https://doi.org/10.1182/blood.V130.Suppl_1.811.811

Published: 2017

Journal Articles

A Critical Role for Donor-Derived IL-22 in Cutaneous Chronic Gvhd

Blood (2017) 130 (Supplement 1): 69.

https://doi.org/10.1182/blood.V130.Suppl_1.69.69

Published: 2017

Journal Articles

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma

Lori A Leslie, MD, Lori A. Leslie, MD, Tatyana A Feldman, MD, Alan P Skarbnik, MD, David H. Vesole, MD PhD, Scott D. Rowley, MD FACP, Andrew L. Pecora, MD, Andre Goy, MD, Michele L. Donato, MD

Blood (2016) 128 (22): 5843.

https://doi.org/10.1182/blood.V128.22.5843.5843

Published: 2016

Journal Articles

Checkpoint Inhibitor Therapy and Graft Versus Host Disease in Allogeneic Bone Marrow Transplant Recipients of Haploidentical and Matched Products with Post-Transplant Cyclophosphamide.

Laura K Schoch, MS, CRNP, Ivan Borrello, MD, Ephraim J. Fuchs, MD, Javier Bolanos-Meade, MD, Jeffrey Sean Huo, MD PhD, Ivana Gojo, MD, Nina Wagner-Johnston, MD, Gabrielle T Prince, MD, Shannon R. McCurdy, MD, B. Douglas Smith, MD, Amy E. DeZern, MD MHS, Margaret M. Showel, MD, David Loeb, MD PhD, Aziza T. Shad, MD, Richard J Jones, MD, Richard F. Ambinder, MD PhD, Douglas Gladstone, MD

Blood (2016) 128 (22): 4571.

https://doi.org/10.1182/blood.V128.22.4571.4571

Published: 2016

Journal Articles

Second-Generation Relative Donor for T-Replete Haplo-Identical Allogeneic Stem Cell Transplantation with High-Dose Post-Transplant Cyclophosphamide: Towards Disappearance of the HLA Barrier

Patrice Chevallier, MD PhD, Pierre Peterlin, MD, Alice Garnier, MD, Beatrice Mahe, MD, Viviane Dubruille, MD, Nicolas Blin, MD, Maud Voldoire, MD, Thomas Gastinne, MD, Cyrille Touzeau, MD PhD, Steven Le Gouill, MD PhD, Marie-Christine Bene, MD, Yannick LE Bris, PharmD, Philippe Moreau, Thierry Guillaume, MD PhD

Blood (2015) 126 (23): 5519.

https://doi.org/10.1182/blood.V126.23.5519.5519

Published: 2015

Journal Articles

A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies

Bradley M. Haverkos, MD MPH, Katie Cortright, BS, Leslie A. Andritsos, MD, William Blum, MD, Rebecca B. Klisovic, MD, Sumithira Vasu, MBBS, David M Goldenberg, ScD, MD, William A Wegener, MD PhD, Steven M. Devine, MD, Samantha M. Jaglowski, MD MPH

Blood (2014) 124 (21): 1168.

https://doi.org/10.1182/blood.V124.21.1168.1168

Published: 2014

Journal Articles

Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

Marie-Charlotte Brüggen, Irene Klein, Hildegard Greinix, Wolfgang Bauer, Zoya Kuzmina, Werner Rabitsch, Peter Kalhs, Peter Petzelbauer, Robert Knobler, Georg Stingl, Georg Stary

Blood (2014) 123 (2): 290–299.

https://doi.org/10.1182/blood-2013-07-514372

Published: 2014

Includes: Supplemental data

Journal Articles

IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells

Hemamalini Bommiasamy, Ph.D., Laura Ott, Ph.D., Shelly West, B.S., LeShara M Fulton, Ph.D., Angela Panoskaltsis-Mortari, Bruce R Blazar, MD, Lynette Fouser, PhD, Jonathan Serody, MD

Blood (2013) 122 (21): 4482.

https://doi.org/10.1182/blood.V122.21.4482.4482

Published: 2013

Journal Articles

Organ-Specific Protection By Bortezomib On The Treatment Of Cutaneous Chronic and Acute GvHD

Chien-Chun Pai, Annie Mirsoian, Steven Grossenbacher, Erik Ames, Kai Sun, MD.PhD, Mingyi Chen, MD, PhD, Bruce R Blazar, MD, Mehrdad Abedi, MD, William J Murphy, PhD

Blood (2013) 122 (21): 4473.

https://doi.org/10.1182/blood.V122.21.4473.4473

Published: 2013

Journal Articles

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

Blood (2013) 122 (21): 153.

https://doi.org/10.1182/blood.V122.21.153.153

Published: 2013

Journal Articles

Diverse T Cell Responses Lead To The Different Manifestations Of Cutaneous Graft-Versus-Host Disease

Marie-Charlotte Brüggen, MD, Irene Klein, MSc, Wolfgang Bauer, MD, Hildegard T Greinix, MD, Zoya Kuzmina, MD, Werner Rabitsch, MD, Peter Kalhs, MD, Robert M Knobler, MD, Georg Stingl, MD, Georg Stary, MD

Blood (2013) 122 (21): 4598.

https://doi.org/10.1182/blood.V122.21.4598.4598

Published: 2013

Journal Articles

Histological Assessment of Cutaneous Acute Graft-Versus-Host Disease in a Preclinical Swine Model of Hematopoietic Cell Transplantation and Vascularized Skin Flap Tolerance

George F. Murphy, MD, Raimon Duran-Struuck, DVM, PhD, Evan A. Farkash, MD, PhD, Mihail Climov, MD, David A. Leonard, MD, Curtis L. Cetrulo, Jr., MD, Thomas R. Spitzer, MD, David H. Sachs, MD, Christene A. Huang, PhD

Blood (2012) 120 (21): 1894.

https://doi.org/10.1182/blood.V120.21.1894.1894

Published: 2012

Journal Articles

Stat3 Activation in Donor CD4 T-Cells Is Critical for Acute Gvhd

Katsutoshi Ozaki, Haruko Matsu, MD, PhD, Keiko Hatanaka, Akiko Meguro, MD, PhD, Iekuni Oh, MD, PhD, Raine Tatara, MD, PhD, Takahiro Suzuki, Masaki Mori, M.D, Ph.D, Tadashi Nagai, MD, PhD, Kazuo Muroi, MD, PhD, Keiya Ozawa, M.D, Ph.D

Blood (2011) 118 (21): 1906.

https://doi.org/10.1182/blood.V118.21.1906.1906

Published: 2011

NARROW

Diagnostic Potential of Five Different Biomechanical Parameters to Detect Sclerotic Cutaneous Graft-Versus-Host Disease

Large Granular Lymphocytosis and Its Impact on Long Term Clinical Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation: 14-Year Follow-up Data

Interobserver Reproducibility of the Myoton and Durometer Devices to Measure Skin Stiffness and Hardness in Chronic Cutaneous Graft-Versus-Host Disease Patients

A Case Report of the Benefit of Cannabidiol (Cannabidiol (CBD)-Predominant Medical Cannabis Preparation) in the Management of Refractory Skin Graft Vs Host Disease (GVHD)

Outcomes after Third Party, Viral-Specific, Cytotoxic Lymphocytes for Immunosuppression- and Epstein-Barr Virus-Associated Lymphoproliferative Disease

Hedgehog Pathway Inhibitor for Treatment of Steroid-Refractory Sclerodermatous Chronic Graft-Versus-Host Disease (GVHD)

Stem Cell Transplantation in Advanced Stage Sickle Cell Disease with Haploidentical T-Cell Depleted PBSC Yields Comparable Outcomes to Matched Sibling Donor Bone Marrow: Results of a Pilot Study

Remissions of Acute Myeloid Leukemia and Blastic Plasmacytoid Dendritic Cell Neoplasm Following Treatment with CD123-Specific CAR T Cells: A First-in-Human Clinical Trial

A Critical Role for Donor-Derived IL-22 in Cutaneous Chronic Gvhd

Long-Term Survival and Absence of Late Relapses in Patients Who Underwent Allogeneic Stem Cell Transplantation for Advanced Cutaneous T-Cell Lymphoma

Checkpoint Inhibitor Therapy and Graft Versus Host Disease in Allogeneic Bone Marrow Transplant Recipients of Haploidentical and Matched Products with Post-Transplant Cyclophosphamide.

Second-Generation Relative Donor for T-Replete Haplo-Identical Allogeneic Stem Cell Transplantation with High-Dose Post-Transplant Cyclophosphamide: Towards Disappearance of the HLA Barrier

A Phase I Study of Milatuzumab for Prevention of Acute Graft Versus Host Disease Following Reduced-Intensity Conditioning Allogeneic Stem Cell Transplant in Patients with Hematologic Malignancies

Diverse T-cell responses characterize the different manifestations of cutaneous graft-versus-host disease

IL-22 Is Critical To The Pathogenesis Of Cutaneous Gvhd Mediated By Th17 Cells

Organ-Specific Protection By Bortezomib On The Treatment Of Cutaneous Chronic and Acute GvHD

Lymphodepletion Followed By Suicide-Gene-Transduced Donor Lymphocyte Infusion: A Strategy To Safely Enhance The Graft-Versus-Tumor Effect

Diverse T Cell Responses Lead To The Different Manifestations Of Cutaneous Graft-Versus-Host Disease

Histological Assessment of Cutaneous Acute Graft-Versus-Host Disease in a Preclinical Swine Model of Hematopoietic Cell Transplantation and Vascularized Skin Flap Tolerance

Stat3 Activation in Donor CD4 T-Cells Is Critical for Acute Gvhd

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only